Susquehanna International Group, LLP Aspira Women'S Health Inc. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.4 - $1.09 $18,116 - $49,368	45,292 New	45,292 $27,000
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $58,327 - $119,968	-66,281 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $6,738 - $14,179	4,134 Added 6.65%	66,281 $117,000
Q3 2021 Nov 15, 2021	SELL	$3.19 - $5.48 $597,238 - $1.03 Million	-187,222 Reduced 75.08%	62,147 $202,000
Q2 2021 Aug 11, 2021	BUY	$4.78 - $6.84 $483,841 - $692,358	101,222 Added 68.33%	249,369 $1.4 Million
Q1 2021 May 17, 2021	BUY	$5.9 - $9.13 $526,209 - $814,286	89,188 Added 151.27%	148,147 $1 Million
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.71 $60,819 - $136,031	20,273 Added 52.4%	58,959 $396,000
Q2 2020 Aug 14, 2020	BUY	$0.78 - $5.25 $30,175 - $203,101	38,686 New	38,686 $149,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.